Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 13:37 (890 d 11:43 ago) – Posting: # 19925
Views: 1,216

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,589 posts in 4,512 threads, 1,530 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Sunday 02:20 CEST (Europe/Vienna)

Maturity is the capacity to endure uncertainty.    John Finley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5